Transforming BioPharma AIfrom Experimentationto Execution
A curated half-day AI Acceleration Forum showcasing how Kedrion and InstaLILY are operationalizing AI responsibly and at scale.
Partners Driving the Summit
The BioPharma industry is crowded with AI “experiments” that never leave the lab. While others are stuck in pilot purgatory, we are focusing on acceleration.
The Kedrion x InstaLILY AI and Innovation Summit is a curated, half-day intensive designed to dismantle the barriers between AI strategy and enterprise-wide execution. This isn't a theoretical look at the future, it is a roadmap for how Kedrion and InstaLILY are operationalizing AI responsibly, at scale, right now.
The partnership between Kedrion and InstaLILY represents the frontier of BioPharma. By combining deep industry expertise with rapid execution, we are moving past the “hype cycle” to build AI systems that actually work within the rigors of regulated environments.
Voices Shaping the Summit
As part of NYC Tech Week, Kedrion and InstaLILY AI have curated a half-day AI and Innovation Summit designed to move the BioPharma industry from experimentation to execution.
The Kedrion x InstaLILY AI & Innovation Summit will showcase how artificial intelligence is operationalized responsibly, at scale, and inside real-world systems.
Peter Michel
Managing Director
Bob Rossilli
Chief Commercial Officer, Global Business
Paige Bailey
AI Developer Relations Lead
Dmitry Simkhovich
Global Head of Business Intelligence
Amit Shah
Founder & CEO
Andrea Caricasole
Chief Research and Innovation Officer
Duccio Manetti
Chief Communications & Government Affairs Officer
Opening
The AI Inflection Point: From Market Pressure to Operating Model Advantage
Where commercial reality meets structural reinvention.
AI in Action: The Revenue Engine, Live
Experience real-time decision intelligence. Make the tradeoffs. See the impact.
From Architecture to Impact: Operators on What’s Working
What it actually takes to deploy AI responsibly, and make it work.
Networking Break
From Molecule to Mind: The Next Frontier of Intelligence in Healthcare
Where frontier AI meets rare disease, responsibility, and the future of human potential.
Acceleration Labs: From Idea to Deployable AI Opportunity
Leave with a tangible integration blueprint.
Capital, Conviction, and Compounding Value
Investors and operators on compounding advantage.
Aperitivo | Conversations That Compound
Where ideas turn into partnerships.